Author:
Drury-Stewart Danielle N.,Lannert Kerry W.,Chung Dominic W.,Teramura Gayle T.,Zimring James C.,Konkle Barbara A.,Gammill Hilary S.,Johnsen Jill M.
Publisher
Public Library of Science (PLoS)
Reference53 articles.
1. Laboratory Assessment of von Willebrand Factor: Altered Interpretation of Laboratory Data, and Altered Diagnosis of von Willebrand's Disease;EJ Favaloro;Clinical and Applied Thrombosis/Hemostasis,1997
2. Lenting PJ, Denis CV, Wohner N (2013) Von Willebrand factor and thrombosis: risk factor, actor and pharmacological target. Curr Vasc Pharmacol 11: 448–456. CVP-54233 [pii].
3. Johnsen JM, Ginsburg D (2010) von Willebrand Disease. In: Kaushansky K, Licthman MA, Beutler E, Kipps TJ, Seligsohn U, et al., editors. Williams Hematology. New York: McGraw Hill, Inc. pp. 2069–2087.
4. Assessment of von Willebrand factor propeptide improves the diagnosis of von Willebrand disease;A Casonato;Semin Thromb Hemost,2011
5. VWF propeptide and ratios between VWF, VWF propeptide, and FVIII in the characterization of type 1 von Willebrand disease;J Eikenboom;Blood,2013
Cited by
50 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献